CASC9 was firstly reported in esophageal cancer as an oncogene [15] and was subsequently confirmed to be associated with the occurrence and development of several cancers, such as breast cancer [16], gastric cancer [17] and colorectal cancer [18]. The gene discussed is CASC9; the disease is breast carcinoma.